Opinion

Video

Utilizing RWE to Derive Optimal Treatment Strategy for Refractory mCRC

Richard Kim, MD, discusses the significance of real-world evidence when selecting treatment sequencing strategy.

Related Videos
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on data for neoadjuvant nivolumab plus ipilimumab in dMMR colon cancer.
Yair Lotan, MD, UT Southwestern Medical Center
Alex Herrera, MD
Bertram Yuh, MD, MISM, MSHCPM
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Idoroenyi Amanam, MD